CD19-CART Treatment for ALL

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2018
This study aims to evaluate the safety and efficacy of a novel CD19-CART in the treatment of refractory or recurrent ALL.
Epistemonikos ID: 19e18bc51c63cbbbfffe31e7b3b8bac7b91e4a47
First added on: May 21, 2024